File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.12809/hkmj187673
- Scopus: eid_2-s2.0-85067903467
- WOS: WOS:000472511700005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021
Title | Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021 |
---|---|
Authors | |
Keywords | Antirheumatic agents Arthritis Drug costs Health expenditures Hong Kong Janus kinases Rheumatoid |
Issue Date | 2019 |
Publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/ |
Citation | Hong Kong Medical Journal, 2019, v. 25 n. 3, p. 201-208 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/276092 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.261 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, X | - |
dc.contributor.author | Pathadka, S | - |
dc.contributor.author | Man, KK | - |
dc.contributor.author | Wong, ICK | - |
dc.contributor.author | Chan, EWY | - |
dc.date.accessioned | 2019-09-10T02:55:47Z | - |
dc.date.available | 2019-09-10T02:55:47Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Hong Kong Medical Journal, 2019, v. 25 n. 3, p. 201-208 | - |
dc.identifier.issn | 1024-2708 | - |
dc.identifier.uri | http://hdl.handle.net/10722/276092 | - |
dc.language | eng | - |
dc.publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/ | - |
dc.relation.ispartof | Hong Kong Medical Journal | - |
dc.rights | Hong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press. | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Antirheumatic agents | - |
dc.subject | Arthritis | - |
dc.subject | Drug costs | - |
dc.subject | Health expenditures | - |
dc.subject | Hong Kong | - |
dc.subject | Janus kinases | - |
dc.subject | Rheumatoid | - |
dc.title | Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021 | - |
dc.type | Article | - |
dc.identifier.email | Li, X: sxueli@hku.hk | - |
dc.identifier.email | Pathadka, S: swathip@hku.hk | - |
dc.identifier.email | Wong, ICK: wongick@hku.hk | - |
dc.identifier.email | Chan, EWY: ewchan@hku.hk | - |
dc.identifier.authority | Li, X=rp02531 | - |
dc.identifier.authority | Wong, ICK=rp01480 | - |
dc.identifier.authority | Chan, EWY=rp01587 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.12809/hkmj187673 | - |
dc.identifier.scopus | eid_2-s2.0-85067903467 | - |
dc.identifier.hkuros | 303041 | - |
dc.identifier.volume | 25 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 201 | - |
dc.identifier.epage | 208 | - |
dc.identifier.isi | WOS:000472511700005 | - |
dc.publisher.place | Hong Kong | - |
dc.identifier.issnl | 1024-2708 | - |